Turning to drugs to beat the downturn
In the latest issue of MoneyWeek, out now, John Stepek examines the reputation of pharmaceutical stocks as a safe haven in an economic slowdown.
Not yet a subscriber? Sign up for a three-week free trial to read this issue right now.
Grim reality overtakes the markets once again
Like it or not, the UK's economy is built on houses. And with more bad news for property on the way, now is the time to take cover and wait for the carnage to pass, says John Stepek.
How to tell if gold's bull market is threatened
With gold in a bull market since 2001, the trick is to stay invested for as long as possible and not be fooled by short term noise. But how do you do this?
Oil price slips as demand subsides – is this the end of the boom?
Oil prices are currently falling from record highs. But given Asia's continuing industrialisation and ongoing supply problems, it should merely prove a correction in a long-term bull run.
Could we see another lost decade for stocks?
Long dry spells aren't uncommon for stock markets, and the post 2000 bear market is unlikely to have worn itself out yet. Everyone is waiting for a sign to buy, but none is forthcoming.
A refined voyage around the Med
There are fewer better ways to spend a relaxing few days than to taste...
Big pharma: cure for a downturn?
Investors are flocking back to pharmaceuticals as a safe haven. But...
Capitalists are morons
Sure, capitalists are greedy. And sure, many of them make mistakes....
